Dr. Reddy’s receives EIR from USFDA for Srikakulam Plant

21 Sep 2017 Evaluate

Dr. Reddy’s Laboratories has received an Establishment Inspection Report (EIR) for its Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh from the US Food and Drug Administration (USFDA).

Recently, USFDA had completed the inspection at Dr. Reddy’s API Mirfield Plant, United Kingdom on September 15, 2017. The company had been issued a Form 483 with three observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1235.15 18.00 (1.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×